| |
| |
|
| Insider
Information: |
Wolf John Peter Iii |
| Relationship: |
Officer |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
270 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$106 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
270 |
|
|
| Total
Value |
$106 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viropharma Inc |
VPHM |
VP, General Counsel |
2014-01-24 |
0 |
2011-11-07 |
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Officer |
2016-12-30 |
270 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
General Counsel and Corp. Sec. |
• – – |
2016-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
270 |
|
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2014-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(48,878) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2014-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
48,878 |
48,878 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2014-01-24 |
4 |
D |
$50.00 |
$5,538,400 |
D/D |
(110,768) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2014-01-17 |
4 |
OE |
$5.91 |
$794,817 |
D/D |
69,785 |
110,768 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2013-12-18 |
4 |
D |
$49.74 |
$2,969,279 |
D/D |
(59,696) |
40,983 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2013-12-18 |
4 |
OE |
$5.91 |
$1,468,392 |
D/D |
100,227 |
45,574 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2012-12-03 |
4 |
S |
$24.85 |
$447,257 |
D/D |
(18,000) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• • – |
2012-12-03 |
4 |
OE |
$3.14 |
$56,520 |
D/D |
18,000 |
18,000 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• – – |
2011-11-07 |
4 |
S |
$21.08 |
$258,194 |
D/D |
(12,250) |
0 |
0 |
- |
|
| VPHM |
Viropharma Inc |
VP, General Counsel |
• – – |
2011-11-07 |
4 |
OE |
$2.44 |
$29,890 |
D/D |
12,250 |
12,250 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
